Pancreatic Cancer Research

ResearcherAir Force Medical UniversityActive in the last 2 years

Yan Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5123337706. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. Co-author DOI 10.1002/advs.202512978↗
  2. mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer. Last author DOI 10.3390/ijms16023267↗
  3. miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. First author DOI 10.1186/1476-4598-12-81↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengnan Lv · 1 shared paper, 2026 · strength 0.29
  2. Feng Wei · 1 shared paper, 2026 · strength 0.29
  3. Bao‐Lian Su · 1 shared paper, 2026 · strength 0.29
  4. Xinyu Peng · 1 shared paper, 2026 · strength 0.29
  5. Wei Feng · 2 shared papers, 2013–2015 · strength 0.10
  6. Guangyi Wang · 2 shared papers, 2013–2015 · strength 0.10
  7. Zifan Lu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.